BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.

CDKN2A and BAP1 germline mutations predispose to melanoma and mesothelioma

Casalone, E;GIRONI, LAURA CRISTINA;GIORGIONE, ROSA;CASADIO, Caterina;COLOMBO, ELISABETTA MARTA;BRACCO, CECILIA;RIGHI, Luisella;PAPOTTI, Mauro Giulio;MATULLO, Giuseppe;PASINI, Barbara
Co-last
;
2016-01-01

Abstract

BAP1 germline mutations predispose to a cancer predisposition syndrome that includes mesothelioma, cutaneous melanoma, uveal melanoma and other cancers. This co-occurrence suggests that these tumors share a common carcinogenic pathway. To evaluate this hypothesis, we studied 40 Italian families with mesothelioma and/or melanoma. The probands were sequenced for BAP1 and for the most common melanoma predisposition genes (i.e. CDKN2A, CDK4, TERT, MITF and POT1) to investigate if these genes may also confer susceptibility to mesothelioma. In two out of six families with both mesothelioma and melanoma we identified either a germline nonsense mutation (c.1153C > T, p.Arg385*) in BAP1 or a recurrent pathogenic germline mutation (c.301G > T, p.Gly101Trp) in CDKN2A. Our study suggests that CDKN2A, in addition to BAP1, could be involved in the melanoma and mesothelioma susceptibility, leading to the rare familial cancer syndromes. It also suggests that these tumors share key steps that drive carcinogenesis and that other genes may be involved in inherited predisposition to malignant mesothelioma and melanoma.
2016
120
130
Asbestos exposure; Cancer predisposition syndrome
Betti, M; Aspesi, A; Biasi, A; Casalone, E; Ferrante, D; Ogliara, P; Gironi, Lc; Giorgione, R; Farinelli, P; Grosso, F; Libener, R; Rosato, S; Turchet...espandi
File in questo prodotto:
File Dimensione Formato  
Betti et al. 2016 Cancer Letters.pdf

Accesso aperto

Tipo di file: POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione 1.63 MB
Formato Adobe PDF
1.63 MB Adobe PDF Visualizza/Apri
2016_Betti.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
1-s2.0-S0304383516303068-main.pdf

Accesso riservato

Tipo di file: PDF EDITORIALE
Dimensione 2.38 MB
Formato Adobe PDF
2.38 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1562052
Citazioni
  • ???jsp.display-item.citation.pmc??? 30
  • Scopus 64
  • ???jsp.display-item.citation.isi??? 61
social impact